Seth Berkley

Richard had had money for epidemic vaccine production.

So he right away was able to make some grants, including the first gland to Moderna for their clinical lot.

And so this was really, you know, we basically sat around and proverbially writing it out on a

on what it would look like.

And after Davos, I went back and met with all of the partners of the alliance and he went back and began to scale up.

And that really was the launch of COVAX, which is ultimately the largest and fastest rollout of vaccine in history, although it had all kinds of problems.

And one of the reasons I wrote the book was to try to document that, both the good and bad, because if you don't follow history, you're doomed to repeat it.

So that's a little bit of a start.

It actually isn't in Ghana.

Sorry.

39 days, it was in India, and the reason was because—

India's regulatory authority had already approved it, but WHO hadn't pre-qualified it.

That's a requirement for us for countries that have weaker systems.

It was another 43 days after that before it hit Ghana and Cote d'Ivoire.

We felt bad about that because we had vaccine doses ready to go.

That's one of the lessons is how do we get faster approvals moving forward.

But after that launch in Africa,

Another 42 days after that, we were in 100 countries.

So this was fast rollout.

Yeah, I mean, the first thing was, of course, without any money, we couldn't do anything.